Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

VanEck Pharmaceutical ETF (NQ:PPH)

92.37 +0.53 (+0.58%)
Official Closing Price Updated: 4:15 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 210,675
Open 91.92
Bid (Size) 92.37 (5)
Ask (Size) 92.40 (75)
Prev. Close 91.84
Today's Range 91.92 - 92.58
52wk Range 77.67 - 95.13
Shares Outstanding N/A
Dividend Yield 2.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure. 
Via Benzinga
Topics ETFs Government
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
Now may be the time to invest in drug companies, as they just slipped the tariff noose. 
Via The Motley Fool
Topics ETFs Government World Trade

Performance

YTD
+7.0%
+7.0%
1 Month
+4.2%
+4.2%
3 Month
+7.6%
+7.6%
6 Month
+11.0%
+11.0%
1 Year
-1.3%
-1.3%

More News

Read More
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Via Benzinga
Topics ETFs
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Via Benzinga
Topics Government World Trade
AstraZeneca Q2 Beats On Cancer Drug Sales, Maintains Guidance — Shares Rise Premarket As Retail Cheers
Via Stocktwits
Pharma Tariffs Back In Spotlight On New Trump Threat
Via Investor's Business Daily
Topics ETFs Government World Trade
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Via Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Via Benzinga
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided
Via Stocktwits
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Via Benzinga
Topics Government World Trade
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report
Via Stocktwits
Topics Government
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Via Benzinga
FDA Aims To Reduce Drug Application Review Time With New Voucher Program
Via Stocktwits
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work
Via Investor's Business Daily
Topics ETFs Government
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Via Benzinga
Topics Government
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Via Benzinga
Topics ETFs Government
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises
Via Stocktwits
Topics Earnings
Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
Via Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Via InvestorPlace
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Via Talk Markets
Topics ETFs
VanEck Announces Year-End Distributions for VanEck Equity ETFs
From VanEck
Via Business Wire

Frequently Asked Questions

Is VanEck Pharmaceutical ETF publicly traded?
Yes, VanEck Pharmaceutical ETF is publicly traded.
What exchange does VanEck Pharmaceutical ETF trade on?
VanEck Pharmaceutical ETF trades on the Nasdaq Stock Market
What is the ticker symbol for VanEck Pharmaceutical ETF?
The ticker symbol for VanEck Pharmaceutical ETF is PPH on the Nasdaq Stock Market
What is the current price of VanEck Pharmaceutical ETF?
The current price of VanEck Pharmaceutical ETF is 92.37
When was VanEck Pharmaceutical ETF last traded?
The last trade of VanEck Pharmaceutical ETF was at 10/20/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.